Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 49 | 2024 | 2330 | 3.520 |
Why?
|
Islets of Langerhans Transplantation | 24 | 2008 | 740 | 1.890 |
Why?
|
Kidney Transplantation | 40 | 2024 | 4235 | 1.860 |
Why?
|
Tissue and Organ Procurement | 14 | 2024 | 962 | 1.840 |
Why?
|
Transplantation, Heterologous | 28 | 2022 | 2386 | 1.750 |
Why?
|
Islets of Langerhans | 17 | 2005 | 1341 | 1.460 |
Why?
|
Graft Survival | 29 | 2024 | 3820 | 1.360 |
Why?
|
Organ Transplantation | 8 | 2024 | 1157 | 1.360 |
Why?
|
Tissue Donors | 19 | 2024 | 2332 | 1.290 |
Why?
|
Graft Rejection | 33 | 2024 | 4446 | 1.150 |
Why?
|
Liver Failure | 7 | 2021 | 250 | 1.070 |
Why?
|
Perfusion | 4 | 2024 | 1373 | 1.000 |
Why?
|
Bibliometrics | 2 | 2024 | 352 | 0.850 |
Why?
|
Brain Death | 6 | 2021 | 357 | 0.840 |
Why?
|
Immunosuppressive Agents | 25 | 2022 | 4176 | 0.830 |
Why?
|
Antigens, Heterophile | 5 | 2020 | 70 | 0.790 |
Why?
|
Swine | 18 | 2022 | 5915 | 0.780 |
Why?
|
Liver, Artificial | 1 | 2021 | 55 | 0.770 |
Why?
|
Organ Preservation | 9 | 2024 | 382 | 0.640 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 4 | 2015 | 506 | 0.630 |
Why?
|
Mycophenolic Acid | 12 | 2011 | 349 | 0.620 |
Why?
|
Genes, bcl-2 | 6 | 2004 | 119 | 0.610 |
Why?
|
Animals, Genetically Modified | 13 | 2022 | 1561 | 0.590 |
Why?
|
Physicians, Women | 1 | 2024 | 509 | 0.590 |
Why?
|
Tacrolimus | 7 | 2018 | 733 | 0.560 |
Why?
|
Chemoembolization, Therapeutic | 5 | 2016 | 128 | 0.560 |
Why?
|
Estradiol | 5 | 2005 | 1937 | 0.560 |
Why?
|
Reperfusion Injury | 8 | 2012 | 1023 | 0.490 |
Why?
|
Pancreas Transplantation | 12 | 2004 | 197 | 0.480 |
Why?
|
Papio | 9 | 2022 | 669 | 0.460 |
Why?
|
Kidney Diseases | 4 | 2021 | 2091 | 0.460 |
Why?
|
Living Donors | 4 | 2020 | 641 | 0.450 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2013 | 7 | 0.450 |
Why?
|
Alabama | 12 | 2019 | 108 | 0.450 |
Why?
|
Diabetes Mellitus, Experimental | 11 | 2005 | 1119 | 0.440 |
Why?
|
Carcinoma, Hepatocellular | 11 | 2024 | 2297 | 0.430 |
Why?
|
Gene Transfer Techniques | 7 | 2004 | 1206 | 0.420 |
Why?
|
Antibodies, Heterophile | 5 | 2021 | 128 | 0.420 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1463 | 0.420 |
Why?
|
Dilatation | 1 | 2013 | 306 | 0.390 |
Why?
|
Patient Selection | 8 | 2021 | 4244 | 0.360 |
Why?
|
Authorship | 2 | 2024 | 284 | 0.360 |
Why?
|
Cold Ischemia | 2 | 2024 | 71 | 0.350 |
Why?
|
Liver | 14 | 2020 | 7528 | 0.350 |
Why?
|
Cholestasis | 1 | 2013 | 378 | 0.350 |
Why?
|
Liver Neoplasms | 12 | 2024 | 4317 | 0.350 |
Why?
|
Immunoglobulin G | 8 | 2018 | 4544 | 0.340 |
Why?
|
Professional-Family Relations | 1 | 2013 | 495 | 0.330 |
Why?
|
Waiting Lists | 6 | 2021 | 765 | 0.330 |
Why?
|
Donor Selection | 3 | 2021 | 232 | 0.320 |
Why?
|
Liver Cirrhosis | 6 | 2017 | 1935 | 0.320 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2019 | 1349 | 0.320 |
Why?
|
Adenoviridae | 8 | 2007 | 1085 | 0.310 |
Why?
|
Specialization | 1 | 2013 | 778 | 0.310 |
Why?
|
Inflammation Mediators | 5 | 2003 | 1886 | 0.290 |
Why?
|
Liver Diseases | 5 | 2021 | 1297 | 0.280 |
Why?
|
Kidney | 12 | 2022 | 7048 | 0.260 |
Why?
|
End Stage Liver Disease | 2 | 2021 | 352 | 0.260 |
Why?
|
Physicians | 1 | 2024 | 4591 | 0.260 |
Why?
|
Leukocytes, Mononuclear | 3 | 2021 | 1844 | 0.250 |
Why?
|
Cytokines | 10 | 2010 | 7396 | 0.230 |
Why?
|
Hepatitis C | 4 | 2018 | 1584 | 0.230 |
Why?
|
Delayed Graft Function | 1 | 2024 | 54 | 0.230 |
Why?
|
Animals | 63 | 2022 | 168475 | 0.230 |
Why?
|
Protein C | 1 | 2004 | 133 | 0.230 |
Why?
|
Glomerulonephritis | 1 | 2006 | 331 | 0.230 |
Why?
|
Humans | 115 | 2024 | 761596 | 0.230 |
Why?
|
Monkey Diseases | 1 | 2004 | 71 | 0.220 |
Why?
|
Male | 86 | 2024 | 360846 | 0.220 |
Why?
|
Social Class | 1 | 2012 | 2004 | 0.220 |
Why?
|
Urinary Bladder | 6 | 1995 | 1152 | 0.220 |
Why?
|
Histocompatibility | 3 | 2021 | 317 | 0.220 |
Why?
|
Yttrium Radioisotopes | 1 | 2024 | 107 | 0.210 |
Why?
|
Survival Analysis | 12 | 2021 | 10090 | 0.210 |
Why?
|
Haplorhini | 1 | 2004 | 525 | 0.210 |
Why?
|
Polylysine | 1 | 2003 | 131 | 0.210 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1435 | 0.210 |
Why?
|
Gene Knockout Techniques | 4 | 2020 | 802 | 0.210 |
Why?
|
Immunotoxins | 8 | 2003 | 175 | 0.210 |
Why?
|
Apoptosis | 10 | 2005 | 9490 | 0.210 |
Why?
|
Nitric Oxide | 3 | 2014 | 2136 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2005 | 1246 | 0.210 |
Why?
|
Macaca mulatta | 17 | 2018 | 2329 | 0.200 |
Why?
|
Family | 1 | 2013 | 3195 | 0.200 |
Why?
|
Antibodies, Monoclonal | 5 | 2019 | 9177 | 0.200 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2003 | 225 | 0.200 |
Why?
|
Postoperative Complications | 13 | 2021 | 15633 | 0.200 |
Why?
|
Galactosyltransferases | 3 | 2019 | 276 | 0.200 |
Why?
|
Health Services Accessibility | 6 | 2019 | 5440 | 0.200 |
Why?
|
Carbohydrates | 2 | 2021 | 390 | 0.190 |
Why?
|
Stents | 1 | 2013 | 3179 | 0.190 |
Why?
|
Kidney Failure, Chronic | 4 | 2024 | 2472 | 0.190 |
Why?
|
Portal Vein | 2 | 2003 | 431 | 0.190 |
Why?
|
Hepatic Artery | 1 | 2002 | 232 | 0.180 |
Why?
|
Microspheres | 1 | 2024 | 784 | 0.180 |
Why?
|
Ureterostomy | 1 | 2000 | 18 | 0.180 |
Why?
|
Endoplasmic Reticulum | 2 | 2005 | 1134 | 0.180 |
Why?
|
Mice, SCID | 8 | 2005 | 2626 | 0.180 |
Why?
|
Cystostomy | 1 | 2000 | 25 | 0.180 |
Why?
|
Oligopeptides | 2 | 2003 | 1187 | 0.180 |
Why?
|
Genetic Vectors | 7 | 2007 | 3396 | 0.180 |
Why?
|
Renal Insufficiency | 1 | 2006 | 809 | 0.170 |
Why?
|
Insulin | 12 | 2004 | 6597 | 0.170 |
Why?
|
Simvastatin | 1 | 2002 | 346 | 0.170 |
Why?
|
Chi-Square Distribution | 6 | 2016 | 3415 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2004 | 3415 | 0.160 |
Why?
|
Middle Aged | 47 | 2024 | 220921 | 0.160 |
Why?
|
Primates | 3 | 2019 | 523 | 0.160 |
Why?
|
Retrospective Studies | 36 | 2024 | 80647 | 0.160 |
Why?
|
Aneurysm | 1 | 2002 | 337 | 0.160 |
Why?
|
Female | 63 | 2024 | 392705 | 0.160 |
Why?
|
Guanidines | 5 | 2003 | 194 | 0.150 |
Why?
|
Cytoprotection | 3 | 2005 | 200 | 0.150 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1526 | 0.150 |
Why?
|
Life Support Care | 1 | 2019 | 226 | 0.150 |
Why?
|
Gastric Antral Vascular Ectasia | 1 | 2017 | 6 | 0.150 |
Why?
|
Models, Animal | 3 | 2019 | 2112 | 0.150 |
Why?
|
Treatment Outcome | 26 | 2024 | 64685 | 0.140 |
Why?
|
Caspases | 4 | 2005 | 879 | 0.140 |
Why?
|
Adult | 40 | 2024 | 221210 | 0.140 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2017 | 63 | 0.140 |
Why?
|
Endothelium, Vascular | 3 | 2003 | 4431 | 0.130 |
Why?
|
Tissue and Organ Harvesting | 2 | 2018 | 373 | 0.130 |
Why?
|
United States | 13 | 2024 | 72340 | 0.130 |
Why?
|
Mixed Function Oxygenases | 1 | 2017 | 265 | 0.130 |
Why?
|
Transplantation Immunology | 1 | 1998 | 532 | 0.130 |
Why?
|
Time Factors | 24 | 2021 | 39969 | 0.120 |
Why?
|
Health Care Rationing | 1 | 2018 | 437 | 0.120 |
Why?
|
Drug Therapy, Combination | 9 | 2021 | 6312 | 0.120 |
Why?
|
Drug Administration Schedule | 3 | 2014 | 4853 | 0.120 |
Why?
|
Organ Preservation Solutions | 3 | 2003 | 100 | 0.120 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3430 | 0.120 |
Why?
|
Rats, Inbred Lew | 3 | 2012 | 1157 | 0.120 |
Why?
|
Drainage | 6 | 1995 | 1157 | 0.120 |
Why?
|
Sirolimus | 2 | 2021 | 1533 | 0.120 |
Why?
|
Enzyme Activation | 4 | 2005 | 3597 | 0.120 |
Why?
|
Risk Adjustment | 1 | 2018 | 600 | 0.120 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2016 | 1188 | 0.120 |
Why?
|
Peritoneovenous Shunt | 1 | 1994 | 9 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8002 | 0.120 |
Why?
|
Lymphocele | 1 | 1994 | 18 | 0.120 |
Why?
|
Amebiasis | 1 | 2014 | 33 | 0.120 |
Why?
|
Mice, Inbred NOD | 3 | 2003 | 1827 | 0.120 |
Why?
|
Bile Ducts | 1 | 2015 | 282 | 0.120 |
Why?
|
Lung Transplantation | 3 | 2021 | 1310 | 0.110 |
Why?
|
Technetium | 1 | 1994 | 317 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3358 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2018 | 803 | 0.110 |
Why?
|
Tissue Survival | 2 | 2003 | 119 | 0.110 |
Why?
|
Arteries | 1 | 2018 | 1123 | 0.110 |
Why?
|
Cholangitis, Sclerosing | 2 | 2013 | 177 | 0.110 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2013 | 86 | 0.110 |
Why?
|
Histocompatibility Testing | 4 | 2019 | 712 | 0.110 |
Why?
|
Transportation | 1 | 2015 | 217 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2006 | 4352 | 0.110 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18255 | 0.110 |
Why?
|
Epitopes | 1 | 2019 | 2503 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2017 | 606 | 0.100 |
Why?
|
Duodenum | 3 | 1995 | 490 | 0.100 |
Why?
|
Sodium Nitrite | 1 | 2012 | 16 | 0.100 |
Why?
|
Organizational Policy | 1 | 2015 | 432 | 0.100 |
Why?
|
Shock, Hemorrhagic | 1 | 2014 | 223 | 0.100 |
Why?
|
B-Lymphocytes | 4 | 2022 | 4758 | 0.100 |
Why?
|
Logistic Models | 4 | 2016 | 13255 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2001 | 2188 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 7 | 2016 | 6484 | 0.090 |
Why?
|
Aged | 20 | 2024 | 169310 | 0.090 |
Why?
|
Policy Making | 1 | 2015 | 542 | 0.090 |
Why?
|
Marital Status | 1 | 2012 | 426 | 0.090 |
Why?
|
Cadaver | 4 | 2003 | 1358 | 0.090 |
Why?
|
Mice | 20 | 2007 | 81539 | 0.090 |
Why?
|
Transplantation, Homologous | 12 | 2003 | 4807 | 0.090 |
Why?
|
Immune Tolerance | 7 | 2003 | 2302 | 0.090 |
Why?
|
Allopurinol | 4 | 2012 | 198 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2001 | 1553 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4514 | 0.090 |
Why?
|
Cell Nucleus | 3 | 2003 | 2910 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1116 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 3 | 2021 | 1881 | 0.090 |
Why?
|
Risk Assessment | 7 | 2021 | 23996 | 0.090 |
Why?
|
Decision Making | 2 | 2014 | 3929 | 0.090 |
Why?
|
Sus scrofa | 2 | 2021 | 428 | 0.090 |
Why?
|
Cell Death | 3 | 2007 | 1679 | 0.080 |
Why?
|
Smad Proteins | 1 | 2010 | 156 | 0.080 |
Why?
|
I-kappa B Proteins | 1 | 2010 | 211 | 0.080 |
Why?
|
Risk Factors | 14 | 2024 | 74213 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1809 | 0.080 |
Why?
|
NF-kappa B | 3 | 2010 | 2490 | 0.080 |
Why?
|
Catheterization | 2 | 2013 | 1428 | 0.080 |
Why?
|
Polyethylene Glycols | 2 | 2005 | 1189 | 0.080 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39106 | 0.080 |
Why?
|
Mice, Inbred C57BL | 9 | 2005 | 22174 | 0.080 |
Why?
|
Muromonab-CD3 | 2 | 1999 | 104 | 0.080 |
Why?
|
Transplantation Tolerance | 2 | 2003 | 605 | 0.080 |
Why?
|
Creatinine | 5 | 2004 | 1899 | 0.070 |
Why?
|
Fatty Liver | 2 | 2012 | 790 | 0.070 |
Why?
|
Age Factors | 6 | 2024 | 18399 | 0.070 |
Why?
|
Raffinose | 3 | 2003 | 53 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1509 | 0.070 |
Why?
|
Down-Regulation | 2 | 2006 | 2919 | 0.070 |
Why?
|
Necrosis | 4 | 2014 | 1611 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 3246 | 0.070 |
Why?
|
Medically Uninsured | 1 | 2013 | 836 | 0.070 |
Why?
|
Caspase 12 | 2 | 2005 | 8 | 0.070 |
Why?
|
Intestinal Mucosa | 2 | 2010 | 3032 | 0.070 |
Why?
|
Gastric Mucosa | 1 | 2010 | 604 | 0.070 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 1998 | 276 | 0.070 |
Why?
|
Helicobacter pylori | 1 | 2010 | 377 | 0.070 |
Why?
|
Methylprednisolone | 5 | 2000 | 385 | 0.070 |
Why?
|
Graft vs Host Disease | 2 | 2018 | 3029 | 0.070 |
Why?
|
Helicobacter Infections | 1 | 2010 | 388 | 0.070 |
Why?
|
T-Lymphocytes | 5 | 2018 | 10194 | 0.070 |
Why?
|
Survival Rate | 8 | 2015 | 12723 | 0.070 |
Why?
|
Blood Glucose | 8 | 2005 | 6391 | 0.070 |
Why?
|
Cause of Death | 2 | 2013 | 3683 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4028 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 1406 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1171 | 0.060 |
Why?
|
Phenylbutyrates | 1 | 2005 | 72 | 0.060 |
Why?
|
Cell Survival | 3 | 2004 | 5791 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2018 | 18966 | 0.060 |
Why?
|
Educational Status | 1 | 2012 | 2522 | 0.060 |
Why?
|
Macrophages | 3 | 2010 | 5767 | 0.060 |
Why?
|
Glutathione | 3 | 2003 | 583 | 0.060 |
Why?
|
Th1 Cells | 1 | 2010 | 1036 | 0.060 |
Why?
|
Reoperation | 5 | 2015 | 4303 | 0.060 |
Why?
|
Radiosurgery | 1 | 2014 | 1342 | 0.060 |
Why?
|
Gene Expression | 4 | 2012 | 7581 | 0.060 |
Why?
|
Kidney Function Tests | 2 | 2024 | 679 | 0.060 |
Why?
|
Transplantation, Isogeneic | 1 | 2004 | 248 | 0.060 |
Why?
|
Hepacivirus | 2 | 2011 | 1336 | 0.060 |
Why?
|
Cyclosporine | 4 | 2000 | 778 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2024 | 2178 | 0.060 |
Why?
|
Pancreas, Artificial | 1 | 2005 | 54 | 0.060 |
Why?
|
Stromal Cells | 2 | 2006 | 1330 | 0.060 |
Why?
|
Trypsinogen | 2 | 1994 | 84 | 0.060 |
Why?
|
Surface-Active Agents | 1 | 2004 | 150 | 0.060 |
Why?
|
Caspase 8 | 1 | 2004 | 190 | 0.060 |
Why?
|
Warm Ischemia | 1 | 2024 | 58 | 0.060 |
Why?
|
Activating Transcription Factor 2 | 1 | 2003 | 44 | 0.060 |
Why?
|
Income | 1 | 2012 | 1877 | 0.060 |
Why?
|
Brefeldin A | 1 | 2003 | 68 | 0.060 |
Why?
|
Streptozocin | 1 | 2004 | 194 | 0.060 |
Why?
|
Calcimycin | 1 | 2003 | 213 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1032 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1379 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1991 | 1935 | 0.050 |
Why?
|
Tunicamycin | 1 | 2003 | 108 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2006 | 696 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2014 | 5247 | 0.050 |
Why?
|
Thrombosis | 3 | 2003 | 2942 | 0.050 |
Why?
|
Mucous Membrane | 1 | 2006 | 659 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2002 | 122 | 0.050 |
Why?
|
Urologic Diseases | 3 | 1994 | 247 | 0.050 |
Why?
|
Medicaid | 1 | 2016 | 2818 | 0.050 |
Why?
|
Culture Techniques | 1 | 2003 | 531 | 0.050 |
Why?
|
Biopsy | 5 | 2011 | 6766 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2095 | 0.050 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1964 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2003 | 287 | 0.050 |
Why?
|
bcl-Associated Death Protein | 1 | 2002 | 102 | 0.050 |
Why?
|
Adenosine | 3 | 2003 | 808 | 0.050 |
Why?
|
Neutrophils | 3 | 2005 | 3767 | 0.050 |
Why?
|
Caspase 9 | 1 | 2002 | 185 | 0.050 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12463 | 0.050 |
Why?
|
Bioethics | 1 | 2004 | 117 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2003 | 1762 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2003 | 574 | 0.050 |
Why?
|
Length of Stay | 5 | 2015 | 6426 | 0.050 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 216 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2006 | 756 | 0.050 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 727 | 0.050 |
Why?
|
Caspase 3 | 1 | 2004 | 731 | 0.050 |
Why?
|
Hepatectomy | 2 | 2005 | 557 | 0.050 |
Why?
|
Program Evaluation | 2 | 2021 | 2495 | 0.050 |
Why?
|
Iliac Vein | 1 | 2002 | 70 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2003 | 321 | 0.050 |
Why?
|
Transfection | 5 | 2002 | 5774 | 0.050 |
Why?
|
Neuraminic Acids | 1 | 2021 | 16 | 0.050 |
Why?
|
Elapid Venoms | 1 | 2021 | 40 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1940 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 441 | 0.050 |
Why?
|
Quercetin | 1 | 2002 | 97 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2006 | 823 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1913 | 0.050 |
Why?
|
Oncolytic Virotherapy | 1 | 2007 | 516 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5493 | 0.050 |
Why?
|
Preoperative Care | 3 | 2005 | 2242 | 0.050 |
Why?
|
Monocytes | 2 | 2010 | 2570 | 0.050 |
Why?
|
Arginine | 1 | 2004 | 934 | 0.050 |
Why?
|
Cercopithecidae | 1 | 2020 | 22 | 0.050 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 502 | 0.050 |
Why?
|
Insurance, Health | 1 | 2013 | 2499 | 0.050 |
Why?
|
Transcription Factors | 4 | 2005 | 12130 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2003 | 586 | 0.040 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2000 | 44 | 0.040 |
Why?
|
Iliac Artery | 1 | 2002 | 343 | 0.040 |
Why?
|
Rats | 3 | 2012 | 23741 | 0.040 |
Why?
|
Hemobilia | 1 | 2000 | 18 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2010 | 2747 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2000 | 174 | 0.040 |
Why?
|
Common Bile Duct | 1 | 2000 | 106 | 0.040 |
Why?
|
Choledochostomy | 1 | 2000 | 16 | 0.040 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2000 | 75 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5485 | 0.040 |
Why?
|
Hepatopulmonary Syndrome | 1 | 1999 | 24 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 891 | 0.040 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12059 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2021 | 487 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2000 | 120 | 0.040 |
Why?
|
Primate Diseases | 1 | 1999 | 15 | 0.040 |
Why?
|
Cholangitis | 1 | 2000 | 111 | 0.040 |
Why?
|
Mitochondria | 2 | 2002 | 3624 | 0.040 |
Why?
|
Cholecystitis | 1 | 2000 | 180 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2004 | 811 | 0.040 |
Why?
|
Treatment Refusal | 1 | 2002 | 429 | 0.040 |
Why?
|
Biliary Tract Diseases | 1 | 2000 | 159 | 0.040 |
Why?
|
Virus Replication | 1 | 2007 | 2435 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2014 | 6228 | 0.040 |
Why?
|
Phosphorylation | 3 | 2010 | 8321 | 0.040 |
Why?
|
Tissue Preservation | 1 | 1999 | 174 | 0.040 |
Why?
|
Glucose | 3 | 2002 | 4347 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2001 | 735 | 0.040 |
Why?
|
Recovery of Function | 3 | 2003 | 2979 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 2 | 1995 | 67 | 0.040 |
Why?
|
Biological Transport | 1 | 2002 | 2091 | 0.040 |
Why?
|
Anastomosis, Surgical | 3 | 2015 | 983 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1999 | 445 | 0.040 |
Why?
|
Gene Silencing | 1 | 2004 | 1509 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29629 | 0.040 |
Why?
|
Health Maintenance Organizations | 1 | 2000 | 659 | 0.040 |
Why?
|
Cost Control | 1 | 2000 | 628 | 0.040 |
Why?
|
Intestines | 1 | 2006 | 1910 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2007 | 1796 | 0.040 |
Why?
|
Azathioprine | 1 | 1999 | 354 | 0.040 |
Why?
|
Transplants | 1 | 2019 | 206 | 0.040 |
Why?
|
Inflammation | 3 | 2014 | 10774 | 0.040 |
Why?
|
Liver Function Tests | 2 | 2014 | 523 | 0.040 |
Why?
|
Diphtheria Toxin | 2 | 2000 | 253 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2006 | 11076 | 0.030 |
Why?
|
Antibodies | 2 | 2022 | 2418 | 0.030 |
Why?
|
Adolescent | 9 | 2014 | 88326 | 0.030 |
Why?
|
Death | 1 | 2021 | 676 | 0.030 |
Why?
|
Hemofiltration | 1 | 1996 | 59 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2003 | 1349 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4576 | 0.030 |
Why?
|
Blood Coagulation Factors | 1 | 1998 | 365 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2002 | 3088 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1997 | 255 | 0.030 |
Why?
|
Blotting, Western | 1 | 2003 | 5035 | 0.030 |
Why?
|
Pilot Projects | 2 | 2000 | 8633 | 0.030 |
Why?
|
Temperature | 1 | 2002 | 2226 | 0.030 |
Why?
|
Prothrombin Time | 1 | 1995 | 117 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 1997 | 329 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5790 | 0.030 |
Why?
|
Hemostatics | 1 | 1998 | 241 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2002 | 1492 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2000 | 700 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2002 | 1616 | 0.030 |
Why?
|
Nephrectomy | 1 | 2000 | 937 | 0.030 |
Why?
|
Platelet Transfusion | 2 | 2014 | 298 | 0.030 |
Why?
|
Cross Reactions | 1 | 2017 | 817 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 1995 | 204 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 1998 | 376 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6534 | 0.030 |
Why?
|
Ammonia | 1 | 1995 | 237 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 351 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2005 | 1868 | 0.030 |
Why?
|
Hemoglobins | 2 | 2017 | 1526 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2002 | 10766 | 0.030 |
Why?
|
Hirschsprung Disease | 1 | 1996 | 163 | 0.030 |
Why?
|
Urography | 1 | 1995 | 316 | 0.030 |
Why?
|
Prednisone | 1 | 1999 | 1563 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 1995 | 416 | 0.030 |
Why?
|
Cystoscopy | 1 | 1994 | 131 | 0.030 |
Why?
|
Fatal Outcome | 2 | 2014 | 1835 | 0.030 |
Why?
|
Registries | 3 | 2019 | 8225 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1668 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2002 | 2457 | 0.030 |
Why?
|
Recurrence | 3 | 2015 | 8466 | 0.030 |
Why?
|
Bilirubin | 1 | 1995 | 436 | 0.030 |
Why?
|
Capsules | 1 | 2014 | 191 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 726 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7968 | 0.030 |
Why?
|
Glucose Tolerance Test | 3 | 2003 | 1178 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7828 | 0.030 |
Why?
|
Biliary Atresia | 1 | 1993 | 88 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2002 | 2865 | 0.030 |
Why?
|
Erythrocyte Transfusion | 2 | 2014 | 570 | 0.030 |
Why?
|
Macaca fascicularis | 3 | 2000 | 903 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 1998 | 2850 | 0.030 |
Why?
|
Urethral Diseases | 1 | 1993 | 52 | 0.030 |
Why?
|
Retreatment | 1 | 2014 | 598 | 0.030 |
Why?
|
Health Care Costs | 3 | 2015 | 3242 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 1995 | 864 | 0.030 |
Why?
|
Serum Albumin | 1 | 1995 | 672 | 0.030 |
Why?
|
Resource Allocation | 1 | 2015 | 350 | 0.030 |
Why?
|
Postoperative Care | 2 | 2002 | 1468 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1203 | 0.020 |
Why?
|
Hip Fractures | 1 | 2000 | 988 | 0.020 |
Why?
|
Nitrites | 1 | 2012 | 159 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1096 | 0.020 |
Why?
|
Urethra | 1 | 1994 | 405 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3701 | 0.020 |
Why?
|
Risk | 1 | 2004 | 9610 | 0.020 |
Why?
|
Odds Ratio | 2 | 2014 | 9647 | 0.020 |
Why?
|
SEER Program | 1 | 2016 | 1450 | 0.020 |
Why?
|
HLA Antigens | 1 | 2017 | 1328 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1301 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2012 | 271 | 0.020 |
Why?
|
Drug Approval | 1 | 2018 | 814 | 0.020 |
Why?
|
Theophylline | 1 | 1991 | 131 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2017 | 5870 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 12149 | 0.020 |
Why?
|
Fetal Tissue Transplantation | 1 | 1991 | 138 | 0.020 |
Why?
|
Aortic Valve | 1 | 2001 | 1955 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2003 | 9542 | 0.020 |
Why?
|
Benzoates | 1 | 2012 | 212 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2003 | 2751 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2014 | 962 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 2001 | 167 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1638 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16592 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 5 | 2014 | 20568 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4937 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2000 | 3733 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1784 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2000 | 1924 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1892 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2001 | 2001 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1998 | 2161 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 1999 | 2656 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 22176 | 0.020 |
Why?
|
Colon | 1 | 1996 | 1792 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6864 | 0.020 |
Why?
|
Intestine, Small | 1 | 1994 | 1206 | 0.020 |
Why?
|
Child | 7 | 2015 | 80158 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5799 | 0.020 |
Why?
|
Organ Size | 2 | 2005 | 2254 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15266 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 74 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 1993 | 802 | 0.020 |
Why?
|
Cohort Studies | 4 | 2015 | 41495 | 0.020 |
Why?
|
Dogs | 4 | 1992 | 3839 | 0.020 |
Why?
|
Coronary Disease | 1 | 2001 | 5914 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 1999 | 2567 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1993 | 1170 | 0.020 |
Why?
|
Cold Temperature | 2 | 2000 | 785 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 1180 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1993 | 1889 | 0.020 |
Why?
|
Thrombelastography | 2 | 1998 | 187 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2002 | 1529 | 0.020 |
Why?
|
Hemodynamics | 2 | 2012 | 4160 | 0.020 |
Why?
|
Dermis | 1 | 2007 | 202 | 0.020 |
Why?
|
Referral and Consultation | 1 | 1998 | 3600 | 0.020 |
Why?
|
Transcription Factor CHOP | 1 | 2005 | 68 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2006 | 522 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5841 | 0.020 |
Why?
|
Mice, Nude | 1 | 1991 | 3614 | 0.010 |
Why?
|
Protein Binding | 1 | 2017 | 9353 | 0.010 |
Why?
|
Hepatitis, Viral, Human | 1 | 2005 | 141 | 0.010 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2005 | 181 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1157 | 0.010 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2005 | 108 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13510 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.010 |
Why?
|
Amylases | 2 | 1994 | 171 | 0.010 |
Why?
|
Liver Regeneration | 1 | 2005 | 213 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 652 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2846 | 0.010 |
Why?
|
Incidence | 2 | 2019 | 21355 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15843 | 0.010 |
Why?
|
Prospective Studies | 4 | 2014 | 54423 | 0.010 |
Why?
|
Hepatitis | 1 | 2005 | 228 | 0.010 |
Why?
|
Blood Urea Nitrogen | 2 | 1994 | 186 | 0.010 |
Why?
|
Renal Circulation | 1 | 2003 | 291 | 0.010 |
Why?
|
Medicare | 2 | 2016 | 6770 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12990 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13642 | 0.010 |
Why?
|
Signal Transduction | 3 | 2012 | 23447 | 0.010 |
Why?
|
Crystallization | 1 | 2003 | 534 | 0.010 |
Why?
|
Cell Movement | 2 | 2006 | 5205 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15733 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2000 | 5368 | 0.010 |
Why?
|
Heart | 1 | 1995 | 4404 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3779 | 0.010 |
Why?
|
Transplantation Conditioning | 2 | 1999 | 1590 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 2016 | 58984 | 0.010 |
Why?
|
Materials Testing | 1 | 2005 | 863 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2007 | 1475 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2003 | 462 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2001 | 509 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 59260 | 0.010 |
Why?
|
Cardioplegic Solutions | 1 | 2000 | 123 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2014 | 3744 | 0.010 |
Why?
|
Fat Necrosis | 1 | 2000 | 60 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 714 | 0.010 |
Why?
|
HIV Infections | 1 | 2006 | 17354 | 0.010 |
Why?
|
Immunoglobulin Fragments | 1 | 2000 | 84 | 0.010 |
Why?
|
Episode of Care | 1 | 2000 | 128 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2000 | 321 | 0.010 |
Why?
|
Capillary Leak Syndrome | 1 | 1999 | 34 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2007 | 21019 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2139 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4001 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3713 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2002 | 837 | 0.010 |
Why?
|
Algorithms | 1 | 2000 | 14033 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2011 | 3060 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3849 | 0.010 |
Why?
|
Aorta, Abdominal | 1 | 2002 | 625 | 0.010 |
Why?
|
Rehabilitation Centers | 1 | 2000 | 246 | 0.010 |
Why?
|
Hot Temperature | 1 | 2005 | 1440 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 687 | 0.010 |
Why?
|
Chimera | 1 | 1999 | 453 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2007 | 3605 | 0.010 |
Why?
|
Gallbladder | 1 | 2000 | 308 | 0.010 |
Why?
|
Umbilical Veins | 1 | 1999 | 426 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6214 | 0.010 |
Why?
|
Infant | 3 | 1994 | 36193 | 0.010 |
Why?
|
Breast | 1 | 2007 | 1967 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2273 | 0.010 |
Why?
|
Lac Operon | 1 | 1997 | 237 | 0.010 |
Why?
|
Blood Component Transfusion | 1 | 1998 | 142 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2001 | 1149 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1998 | 271 | 0.010 |
Why?
|
Intraoperative Period | 1 | 1998 | 510 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2005 | 1403 | 0.010 |
Why?
|
C-Peptide | 1 | 1999 | 440 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 2005 | 1496 | 0.010 |
Why?
|
Antibody Formation | 1 | 2001 | 1395 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1685 | 0.010 |
Why?
|
Fibroblasts | 1 | 2007 | 4142 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2065 | 0.010 |
Why?
|
Chronic Disease | 2 | 2002 | 9319 | 0.010 |
Why?
|
Genes, Viral | 1 | 1997 | 649 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 1999 | 603 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2477 | 0.010 |
Why?
|
Blood Proteins | 1 | 2001 | 1173 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2003 | 2192 | 0.010 |
Why?
|
Factor VIII | 1 | 1998 | 348 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2001 | 1175 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 1996 | 195 | 0.010 |
Why?
|
Cell Count | 1 | 1999 | 1835 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 4920 | 0.010 |
Why?
|
Interleukin-12 | 1 | 1998 | 584 | 0.010 |
Why?
|
Jugular Veins | 1 | 1996 | 210 | 0.010 |
Why?
|
Plasma | 1 | 1998 | 586 | 0.010 |
Why?
|
Fibrinogen | 1 | 1998 | 888 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1995 | 573 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 1997 | 594 | 0.010 |
Why?
|
Child, Preschool | 2 | 1994 | 42232 | 0.010 |
Why?
|
Fibronectins | 1 | 1998 | 723 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 4465 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2639 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1994 | 372 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1999 | 1869 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 1998 | 638 | 0.010 |
Why?
|
Pulmonary Veins | 1 | 1999 | 743 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 3267 | 0.010 |
Why?
|
Placebos | 1 | 1998 | 1667 | 0.010 |
Why?
|
Autoimmunity | 1 | 2002 | 1356 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 1997 | 1073 | 0.010 |
Why?
|
Anal Canal | 1 | 1996 | 373 | 0.010 |
Why?
|
Cell Cycle | 1 | 2002 | 2932 | 0.010 |
Why?
|
Fasting | 1 | 2000 | 1603 | 0.010 |
Why?
|
Isoantibodies | 1 | 1997 | 674 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1997 | 1085 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15601 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1603 | 0.010 |
Why?
|
Hematuria | 1 | 1994 | 233 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1999 | 1784 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1998 | 1154 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12794 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1998 | 942 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1995 | 1972 | 0.010 |
Why?
|
Constipation | 1 | 1996 | 563 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10451 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2003 | 3066 | 0.010 |
Why?
|
Cyclosporins | 1 | 1991 | 216 | 0.010 |
Why?
|
Hyperglycemia | 1 | 1999 | 1376 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1998 | 3162 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8527 | 0.010 |
Why?
|
Transplantation | 1 | 1991 | 219 | 0.010 |
Why?
|
Vaccination | 1 | 2001 | 3384 | 0.000 |
Why?
|
Postoperative Period | 1 | 1994 | 1814 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1999 | 3465 | 0.000 |
Why?
|
Pancreas | 1 | 1995 | 1691 | 0.000 |
Why?
|
Treatment Failure | 1 | 1994 | 2643 | 0.000 |
Why?
|
Blood Platelets | 1 | 1998 | 2479 | 0.000 |
Why?
|
Bone Marrow | 1 | 1997 | 2911 | 0.000 |
Why?
|
Stem Cells | 1 | 1999 | 3524 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 2001 | 11120 | 0.000 |
Why?
|
Diabetic Nephropathies | 1 | 1994 | 973 | 0.000 |
Why?
|
Ischemia | 1 | 1995 | 1884 | 0.000 |
Why?
|
Escherichia coli | 1 | 1997 | 4217 | 0.000 |
Why?
|
Heart Arrest | 1 | 1995 | 1514 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 12973 | 0.000 |
Why?
|
Contrast Media | 1 | 1995 | 5307 | 0.000 |
Why?
|
Acute Disease | 1 | 1992 | 7237 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14665 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 1994 | 20100 | 0.000 |
Why?
|